US launch of weight loss pills boosts Wegovy maker Novo Nordisk
Challenge for Danish group is to capitalise on first-mover advantage to beat Lilly on the US drugmaker’s home turf
Challenge for Danish group is to capitalise on first-mover advantage to beat Lilly on the US drugmaker’s home turf
GLP-1 drugs are reshaping the lives of many, but such treatments can come with a side order of stigma, even shame
Markets remain on edge as crude oil prices stay above $100 a barrel
Weight-loss drug pioneer investing €432m in Athlone to produce Wegovy tablets for all markets outside US
Most major Big Pharma exporters from Ireland likely to escape tariffs under ‘most favoured nation’ deals with White House
Injectables plant designed to help client companies cope with rapidly growing demand for diabetics and obesity medications
For Novo Nordisk Irish country head Dilek Dogan Gurluk, the battle against diabetes is personal
Rare ‘eye strokes’ can cause sudden and permanent vision loss due to reduced blood flow to optic nerve
Danish group Novo Nordisk says Irish plant will serve market for blockbuster weight loss drug outside the US
Eli Lilly reconfigures Irish operation in anticipation of rapid demand for medicines
Swiss drugmaker’s CEO says launch of weight loss pill has been ‘one of the most successful pharmaceutical debuts ever’
Novo Nordisk gained after US firm cancelled competitor to weight-loss drug
Irish market ends week higher as banking shares put in a good performance
Pan-European Stoxx 600 index hits 618.12 points
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices